An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

Clinical trial NCT01453049 · TERMINATED

Trial details

NCT number: NCT01453049
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-04-01
Primary completion: 2010-10-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.